Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder

Biological Psychiatry

Volumn 83, Issue 10, 2018, Pages 866-875

  Mellon, Synthia H ^a   Gautam, Aarti ^b   Hammamieh, Rasha ^b   Jett, Marti ^b   Wolkowitz, Owen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

Animal models; Inflammation; Metabolic syndrome; Metabolomics; Neuroinflammation; PTSD

Indexed keywords

BEHAVIOR DISORDER; COMORBIDITY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEALTH HAZARD; HUMAN; INFLAMMATION; LIFESTYLE; MENTAL HEALTH; META ANALYSIS (TOPIC); METABOLIC REGULATION; METABOLIC SYNDROME X; METABOLISM; METABOLITE; METABOLOMICS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL DISEASE; POSTTRAUMATIC STRESS DISORDER; PRECLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE; COMPLICATION; PHYSIOLOGY; PROCEDURES;

HUMANS; INFLAMMATION; METABOLISM; METABOLOMICS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85045011197     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2018.02.007     Document Type: Review

References (134)

1. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005), 593–602.
2. Santiago, P.N., Ursano, R.J., Gray, C.L., Pynoos, R.S., Spiegel, D., Lewis-Fernandez, R., et al. A systematic review of PTSD prevalence and trajectories in DSM-5 defined trauma exposed populations: intentional and non-intentional traumatic events. PLoS One, 8, 2013, e59236.
3. Kang, H.K., Natelson, B.H., Mahan, C.M., Lee, K.Y., Murphy, F.M., Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: A population-based survey of 30,000 veterans. Am J Epidemiol 157 (2003), 141–148.
4. Kulka, R.A., Schlenger, W.A., Fairbanks, J.A., Hough, R.L., Jordan, B.K., Marmar, C.R., Trauma and the Vietnam War Generation: Report of Findings from the National Vietnam Veterans Readustment Study. 1990, Brunner/Mazel, New York, NY.
5. Tanielian, T., Jaycox, L.E., Invisible Wounds of War: Psychological and Cognitive Inuries, Their Consequences, and Services to Assist Recovery. 2008, RAND Corporation, Santa Monica, CA.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. 2013, American Psychiatric Publishing, Arlington, VA.
7. Levine, A.B., Levine, L.M., Levine, T.B., Posttraumatic stress disorder and cardiometabolic disease. Cardiology 127 (2014), 1–19.
8. Blessing, E., Reus, V.I., Mellon, S.H., Wolkowitz, O.M., Flory, J.D., Bierer, L.M., et al. Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans. Psychoneuroendocrinology 82 (2018), 91–97.
9. O'Donovan, A., Cohen, B.E., Seal, K.H., Bertenthal, D., Margaretten, M., Nishimi, K., et al. Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry 77 (2015), 365–374.
10. Pacella, M.L., Hruska, B., Delahanty, D.L., The physical health consequences of PTSD and PTSD symptoms: A meta-analytic review. J Anxiety Disord 27 (2013), 33–46.
11. Zen, A.L., Whooley, M.A., Zhao, S., Cohen, B.E., Post-traumatic stress disorder is associated with poor health behaviors: Findings from the Heart and Soul study. Health Psychol 31 (2012), 194–201.
12. Michopoulos, V., Vester, A., Neigh, G., Posttraumatic stress disorder: A metabolic disorder in disguise?. Exp Neurol 284 (2016), 220–229.
13. Lohr, J.B., Palmer, B.W., Eidt, C.A., Aailaboyina, S., Mausbach, B.T., Wolkowitz, O.M., et al. Is post-traumatic stress disorder associated with premature senescence? A review of the literature. Am J Geriatr Psychiatry 23 (2015), 709–725.
14. Michopoulos, V., Norrholm, S.D., Jovanovic, T., Diagnostic biomarkers for posttraumatic stress disorder: promising horizons from translational neuroscience research. Biol Psychiatry 78 (2015), 344–353.
15. Su, Y.A., Wu, J., Zhang, L., Zhang, Q., Su, D.M., He, P., et al. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. Int J Biol Sci 4 (2008), 223–235.
16. Zhang, L., Li, H., Hu, X., Benedek, D.M., Fullerton, C.S., Forsten, R.D., et al. Mitochondria-focused gene expression profile reveals common pathways and CPT1B dysregulation in both rodent stress model and human subjects with PTSD. Transl Psychiatry, 5, 2015, e580.
17. Lindqvist, D., Epel, E.S., Mellon, S.H., Penninx, B.W., Revesz, D., Verhoeven, J.E., et al. Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev 55 (2015), 333–364.
18. Lindqvist, D., Mellon, S.H., Dhabhar, F.S., Yehuda, R., Marlene Grenon, S., Flory, J.D., et al. Increased pro-inflammatory milieu in combat related PTSD—a new cohort replication study. Brain Behav Immun 59 (2017), 260–264.
19. Lindqvist, D., Wolkowitz, O.M., Mellon, S., Yehuda, R., Flory, J.D., Henn-Haase, C., et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun 42 (2014), 81–88.
20. O'Donovan, A., Ahmadian, A.J., Neylan, T.C., Pacult, M.A., Edmondson, D., Cohen, B.E., Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study. Brain Behav Immun 60 (2017), 198–205.
21. McFarlane, A.C., Lawrence-Wood, E., Van Hooff, M., Malhi, G.S., Yehuda, R., The need to take a staging approach to the biological mechanisms of PTSD and its treatment. Curr Psychiatry Rep, 19, 2017, 10.
22. Tschopp, J., Mitochondria: Sovereign of inflammation?. Eur J Immunol 41 (2011), 1196–1202.
23. Bersani, F.S., Morley, C., Lindqvist, D., Epel, E.S., Picard, M., Yehuda, R., et al. Mitochondrial DNA copy number is reduced in male combat veterans with PTSD. Prog Neuropsychopharmacol Biol Psychiatry 64 (2016), 10–17.
24. Hammamieh, R., Chakraborty, N., Gautam, A., Muhie, S., Yang, R., Donohue, D., et al. Whole-genome DNA methylation status associated with clinical PTSD. Transl Psychiatry, 7, 2017, e1169.
25. Cohen, H., Matar, M.A., Zohar, J., Maintaining the clinical relevance of animal models in translational studies of post-traumatic stress disorder. ILAR J 55 (2014), 233–245.
26. Friedman, M.J., Keane, T.M., Resick, P.A., Handbook of PTSD: Science and Practice, 2nd ed. 2014, Guilford Press, New York, NY.
27. Wang, Z., Mandel, H., Levingston, C.A., Young, M.R., An exploratory approach demonstrating immune skewing and a loss of coordination among cytokines in plasma and saliva of veterans with combat-related PTSD. Hum Immunol 77 (2016), 652–657.
28. Wang, Z., Young, M.R., PTSD, a disorder with an immunological component. Front Immunol, 7, 2016, 219.
29. Pace, T.W., Heim, C.M., A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun 25 (2011), 6–13.
30. Wang, Z., Caughron, B., Young, M.R.I., Posttraumatic stress disorder: An immunological disorder?. Front Psychiatry, 8, 2017, 222.
31. Lindqvist, D., Mellon, S.H., Dhabhar, F.S., Yehuda, R., Grenon, S.M., Flory, J.D., et al. Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity. Psychiatry Res 258 (2017), 330–336.
32. Bersani, F.S., Wolkowitz, O.M., Milush, J.M., Sinclair, E., Eppling, L., Aschbacher, K., et al. A population of atypical CD56(-)CD16(+) natural killer cells is expanded in PTSD and is associated with symptom severity. Brain Behav Immun 56 (2016), 264–270.
33. Gill, J., Luckenbaugh, D., Charney, D., Vythilingam, M., Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol Psychiatry 68 (2010), 999–1006.
34. Passos, I.C., Vasconcelos-Moreno, M.P., Costa, L.G., Kunz, M., Brietzke, E., Quevedo, J., et al. Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2 (2015), 1002–1012.
35. Banks, W.A., Kastin, A.J., Broadwell, R.D., Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995), 241–248.
36. Liu, B., Hong, J.S., Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 (2003), 1–7.
37. de Pablos, R.M., Herrera, A.J., Espinosa-Oliva, A.M., Sarmiento, M., Munoz, M.F., Machado, A., et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J Neuroinflammation, 11, 2014, 34.
38. Song, C., Phillips, A.G., Leonard, B.E., Horrobin, D.F., Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Mol Psychiatry 9 (2004), 630–638.
39. Johansen, J.P., Cain, C.K., Ostroff, L.E., LeDoux, J.E., Molecular mechanisms of fear learning and memory. Cell 147 (2011), 509–524.
40. Baker, D.G., Ekhator, N.N., Kasckow, J.W., Hill, K.K., Zoumakis, E., Dashevsky, B.A., et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 9 (2001), 209–217.
41. Bonne, O., Gill, J.M., Luckenbaugh, D.A., Collins, C., Owens, M.J., Alesci, S., et al. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J Clin Psychiatry 72 (2011), 1124–1128.
42. Olff, M., van Zuiden, M., Neuroendocrine and neuroimmune markers in PTSD: pre-, peri- and post-trauma glucocorticoid and inflammatory dysregulation. Curr Opin Psychol 14 (2017), 132–137.
43. Brenner, L.A., Stearns-Yoder, K.A., Hoffberg, A.S., Penzenik, M.E., Starosta, A.J., Hernandez, T.D., et al. Growing literature but limited evidence: A systematic review regarding prebiotic and probiotic interventions for those with traumatic brain injury and/or posttraumatic stress disorder. Brain Behav Immun 65 (2017), 57–67.
44. Gocan, A.G., Bachg, D., Schindler, A.E., Rohr, U.D., Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): A pilot study. Horm Mol Biol Clin Investig 10 (2012), 301–314.
45. Hemmings, S.M.J., Malan-Muller, S., van den Heuvel, L.L., Demmitt, B.A., Stanislawski, M.A., Smith, D.G., et al. The microbiome in posttraumatic stress disorder and trauma-exposed controls: An exploratory study. Psychosom Med 79 (2017), 936–946.
46. Eraly, S.A., Nievergelt, C.M., Maihofer, A.X., Barkauskas, D.A., Biswas, N., Agorastos, A., et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 71 (2014), 423–431.
47. Cohen, M., Meir, T., Klein, E., Volpin, G., Assaf, M., Pollack, S., Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int J Psychiatry Med 42 (2011), 117–131.
48. Lopresti, A.L., Drummond, P.D., Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry 45 (2013), 92–99.
49. Rosen, R.L., Levy-Carrick, N., Reibman, J., Xu, N., Shao, Y., Liu, M., et al. Elevated C-reactive protein and posttraumatic stress pathology among survivors of the 9/11 World Trade Center attacks. J Psychiatr Res 89 (2017), 14–21.
50. Michopoulos, V., Rothbaum, A.O., Jovanovic, T., Almli, L.M., Bradley, B., Rothbaum, B.O., et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 172 (2015), 353–362.
51. Miller, M.W., Maniates, H., Wolf, E.J., Logue, M.W., Schichman, S.A., Stone, A., et al. CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein. Brain Behav Immun 67 (2018), 194–202.
52. Amos, T., Stein, D.J., Ipser, J.C., Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev, 2014, CD006239.
53. Birur, B., Math, S.B., Fargason, R.E., A review of psychopharmacological interventions post-disaster to prevent psychiatric sequelae. Psychopharmacol Bull 47 (2017), 8–26.
54. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
55. Borghans, B., Homberg, J.R., Animal models for posttraumatic stress disorder: An overview of what is used in research. World J Psychiatry 5 (2015), 387–396.
56. Schöner, J., Heinz, A., Endres, M., Gertz, K., Kronenberg, G., Post-traumatic stress disorder and beyond: an overview of rodent stress models. J Cell Mol Med 21 (2017), 2248–2256.
57. Deslauriers, J., Toth, M., Der-Avakian, A., Risbrough, V.B., Current status of animal models of posttraumatic stress disorder: Behavioral and biological phenotypes, and future challenges in improving translation. Biol Psychiatry 83 (2018), 895–907.
58. Wilson, C.B., Ebenezer, P.J., McLaughlin, L.D., Francis, J., Predator exposure/psychosocial stress animal model of post-traumatic stress disorder modulates neurotransmitters in the rat hippocampus and prefrontal cortex. PLoS One, 9, 2014, e89104.
59. Deslauriers, J., Powell, S., Risbrough, V.B., Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models. Curr Opin Behav Sci 14 (2017), 123–132.
60. Jones, M.E., Lebonville, C.L., Barrus, D., Lysle, D.T., The role of brain interleukin-1 in stress-enhanced fear learning. Neuropsychopharmacology 40 (2015), 1289–1296.
61. Zimmerman, G., Shaltiel, G., Barbash, S., Cohen, J., Gasho, C.J., Shenhar-Tsarfaty, S., et al. Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFkappaB pathway. Transl Psychiatry, 2, 2012, e78.
62. Muhie, S., Gautam, A., Chakraborty, N., Hoke, A., Meyerhoff, J., Hammamieh, R., et al. Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder. Transl Psychiatry, 7, 2017, e1135.
63. Gautam, A., D'Arpa, P., Donohue, D.E., Muhie, S., Chakraborty, N., Luke, B.T., et al. Acute and chronic plasma metabolomic and liver transcriptomic stress effects in a mouse model with features of post-traumatic stress disorder. PLoS One, 10, 2015, e0117092.
64. Cho, J.H., Lee, I., Hammamieh, R., Wang, K., Baxter, D., Scherler, K., et al. Molecular evidence of stress-induced acute heart injury in a mouse model simulating posttraumatic stress disorder. Proc Natl Acad Sci U S A 111 (2014), 3188–3193.
65. Gamble-George, J.C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C.G., et al. Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife, 5, 2016.
66. Kao, C.Y., He, Z., Henes, K., Asara, J.M., Webhofer, C., Filiou, M.D., et al. Fluoxetine treatment rescues energy metabolism pathway alterations in a posttraumatic stress disorder mouse model. Mol Neuropsychiatry 2 (2016), 46–59.
67. Kao, C.Y., He, Z., Zannas, A.S., Hahn, O., Kuhne, C., Reichel, J.M., et al. Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. J Psychiatr Res 76 (2016), 74–83.
68. Lee, B., Sur, B., Yeom, M., Shim, I., Lee, H., Hahm, D.H., Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 20 (2016), 357–366.
69. Levkovitz, Y., Fenchel, D., Kaplan, Z., Zohar, J., Cohen, H., Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD. Eur Neuropsychopharmacol 25 (2015), 124–132.
70. Deslauriers, J., van Wijngaarde, M., Geyer, M.A., Powell, S., Risbrough, V.B., Effects of LPS-induced immune activation prior to trauma exposure on PTSD-like symptoms in mice. Behav Brain Res 323 (2017), 117–123.
71. Ebenezer, P.J., Wilson, C.B., Wilson, L.D., Nair, A.R., Francis, J., The anti-inflammatory effects of blueberries in an animal model of post-traumatic stress disorder (PTSD). PLoS One, 11, 2016, e0160923.
72. Rosenbaum, S., Stubbs, B., Ward, P.B., Steel, Z., Lederman, O., Vancampfort, D., The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: A systematic review and meta-analysis. Metabolism 64 (2015), 926–933.
73. Wolf, E.J., Schnurr, P.P., PTSD-related cardiovascular disease and accelerated cellular aging. Psychiatr Ann 46 (2016), 527–532.
74. Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 (2006), 4–12.
75. Marsland, A.L., McCaffery, J.M., Muldoon, M.F., Manuck, S.B., Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 59 (2010), 1801–1808.
76. Bartoli, F., Carra, G., Crocamo, C., Carretta, D., Clerici, M., Metabolic syndrome in people suffering from posttraumatic stress disorder: A systematic review and meta-analysis. Metab Syndr Relat Disord 11 (2013), 301–308.
77. Heni, M., Kullmann, S., Preissl, H., Fritsche, A., Haring, H.U., Impaired insulin action in the human brain: Causes and metabolic consequences. Nat Rev Endocrinol 11 (2015), 701–711.
78. Reagan, L.P., Grillo, C.A., Piroli, G.G., The As and Ds of stress: Metabolic, morphological and behavioral consequences. Eur J Pharmacol 585 (2008), 64–75.
79. Wolf, E.J., Bovin, M.J., Green, J.D., Mitchell, K.S., Stoop, T.B., Barretto, K.M., et al. Longitudinal associations between post-traumatic stress disorder and metabolic syndrome severity. Psychol Med 46 (2016), 2215–2226.
80. Gavrieli, A., Farr, O.M., Davis, C.R., Crowell, J.A., Mantzoros, C.S., Early life adversity and/or posttraumatic stress disorder severity are associated with poor diet quality, including consumption of trans fatty acids, and fewer hours of resting or sleeping in a US middle-aged population: A cross-sectional and prospective study. Metabolism 64 (2015), 1597–1610.
81. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
82. Koenen, K.C., Sumner, J.A., Gilsanz, P., Glymour, M.M., Ratanatharathorn, A., Rimm, E.B., et al. Post-traumatic stress disorder and cardiometabolic disease: Improving causal inference to inform practice. Psychol Med 47 (2017), 209–225.
83. Zhang, D., Wang, X., Wang, B., Garza, J.C., Fang, X., Wang, J., et al. Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors. Mol Psychiatry 22 (2017), 1044–1055.
84. Jha, S.K., Jha, N.K., Kumar, D., Ambasta, R.K., Kumar, P., Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in neurodegeneration. Biochim Biophys Acta 1863 (2017), 1132–1146.
85. Wolf, E.J., Miller, D.R., Logue, M.W., Sumner, J., Stoop, T.B., Leritz, E.C., et al. Contributions of polygenic risk for obesity to PTSD-related metabolic syndrome and cortical thickness. Brain Behav Immun 65 (2017), 328–336.
86. Farr, O.M., Ko, B.J., Joung, K.E., Zaichenko, L., Usher, N., Tsoukas, M., et al. Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. Nutr Metab Cardiovasc Dis 25 (2015), 479–488.
87. Tsikunov, S.G., Klyueva, N.N., Kusov, A.G., Vinogradova, T.V., Klimenko, V.M., Denisenko, A.D., Changes in the lipid composition of blood plasma and liver in rats induced by severe psychic trauma. Bull Exp Biol Med 141 (2006), 636–638.
88. Hammamieh, R., Chakraborty, N., De Lima, T.C., Meyerhoff, J., Gautam, A., Muhie, S., et al. Murine model of repeated exposures to conspecific trained aggressors simulates features of post-traumatic stress disorder. Behav Brain Res 235 (2012), 55–66.
89. Chuang, J.C., Cui, H., Mason, B.L., Mahgoub, M., Bookout, A.L., Yu, H.G., et al. Chronic social defeat stress disrupts regulation of lipid synthesis. J Lipid Res 51 (2010), 1344–1353.
90. Czech, B., Neumann, I.D., Müller, M., Reber, S.O., Hellerbrand, C., Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. Int J Clin Exp Pathol 6 (2013), 1585–1593.
91. Sanghez, V., Razzoli, M., Carobbio, S., Campbell, M., McCallum, J., Cero, C., et al. Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the metabolic syndrome. Psychoneuroendocrinology 38 (2013), 2933–2942.
92. Edmondson, D., von Kanel, R., Post-traumatic stress disorder and cardiovascular disease. Lancet Psychiatry 4 (2017), 320–329.
93. Johannessen, K.B., Berntsen, D., Losing the symptoms: Weight loss and decrease in posttraumatic stress disorder symptoms. J Clin Psychol 69 (2013), 655–660.
94. Jia, M., Meng, F., Smerin, S.E., Xing, G., Zhang, L., Su, D.M., et al. Biomarkers in an animal model for revealing neural, hematologic, and behavioral correlates of PTSD. J Vis Exp, 2012, e3361.
95. Cohen, H., Kozlovsky, N., Savion, N., Matar, M.A., Loewenthal, U., Loewenthal, N., et al. An association between stress-induced disruption of the hypothalamic-pituitary-adrenal axis and disordered glucose metabolism in an animal model of post-traumatic stress disorder. J Neuroendocrinol 21 (2009), 898–909.
96. Kalyan-Masih, P., Vega-Torres, J.D., Miles, C., Haddad, E., Rainsbury, S., Baghchechi, M., et al. Western high-fat diet consumption during adolescence increases susceptibility to traumatic stress while selectively disrupting hippocampal and ventricular volumes. eNeuro, 3, 2016.
97. Karabatsiakis, A., Hamuni, G., Wilker, S., Kolassa, S., Renu, D., Kadereit, S., et al. Metabolite profiling in posttraumatic stress disorder. J Mol Psychiatry, 3, 2015, 2.
98. Fielding, B.A., Omega-3 index as a prognosis tool in cardiovascular disease. Curr Opin Clin Nutr Metab Care 20 (2017), 360–365.
99. Dyall, S.C., Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci, 7, 2015, 52.
100. Clay Montier, L.L., Deng, J.J., Bai, Y., Number matters: Control of mammalian mitochondrial DNA copy number. J Genet Genomics 36 (2009), 125–131.
101. Naviaux, R.K., Metabolic features of the cell danger response. Mitochondrion 16 (2014), 7–17.
102. Picca, A., Lezza, A.M.S., Leeuwenburgh, C., Pesce, V., Calvani, R., Landi, F., et al. Fueling inflamm-aging through mitochondrial dysfunction: Mechanisms and molecular targets. Int J Mol Sci, 18, 2017, e933.
103. Sahin, E., Depinho, R.A., Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464 (2010), 520–528.
104. Picard, M., Juster, R.P., McEwen, B.S., Mitochondrial allostatic load puts the ‘gluc’ back in glucocorticoids. Nat Rev Endocrinol 10 (2014), 303–310.
105. Schiavone, S., Trabace, L., Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: A literature overview. Pharmacol Res 107 (2016), 195–204.
106. Zhang, L., Zhou, R., Li, X., Ursano, R.J., Li, H., Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: A possible mechanism for hippocampus atrophy in PTSD. Med Hypotheses 66 (2006), 1205–1208.
107. Kao, C.Y., Anderzhanova, E., Asara, J.M., Wotjak, C.T., Turck, C.W., NextGen Brain microdialysis: Applying modern metabolomics technology to the analysis of extracellular fluid in the central nervous system. Mol Neuropsychiatry 1 (2015), 60–67.
108. Filiou, M.D., Zhang, Y., Teplytska, L., Reckow, S., Gormanns, P., Maccarrone, G., et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry 70 (2011), 1074–1082.
109. Wan, J., Liu, D., Zhang, J., Shi, Y., Han, F., Single-prolonged stress induce different change in the cell organelle of the hippocampal cells: A study of ultrastructure. Acta Histochem 118 (2016), 10–19.
110. Li, X.M., Han, F., Liu, D.J., Shi, Y.X., Single-prolonged stress induced mitochondrial-dependent apoptosis in hippocampus in the rat model of post-traumatic stress disorder. J Chem Neuroanat 40 (2010), 248–255.
111. Liu, D., Xiao, B., Han, F., Wang, E., Shi, Y., Single-prolonged stress induces apoptosis in dorsal raphe nucleus in the rat model of posttraumatic stress disorder. BMC Psychiatry, 12, 2012, 211.
112. Xiao, B., Yu, B., Wang, H.T., Han, F., Shi, Y.X., Single-prolonged stress induces apoptosis by activating cytochrome C/caspase-9 pathway in a rat model of post-traumatic stress disorder. Cell Mol Neurobiol 31 (2011), 37–43.
113. Xing, G., Barry, E.S., Benford, B., Grunberg, N.E., Li, H., Watson, W.D., et al. Impact of repeated stress on traumatic brain injury-induced mitochondrial electron transport chain expression and behavioral responses in rats. Front Neurol, 4, 2013, 196.
114. Garabadu, D., Ahmad, A., Krishnamurthy, S., Risperidone attenuates modified stress-re-stress paradigm-induced mitochondrial dysfunction and apoptosis in rats exhibiting post-traumatic stress disorder-like symptoms. J Mol Neurosci 56 (2015), 299–312.
115. Elmquist, J.K., Scherer, P.E., The cover. Neuroendocrine and endocrine pathways of obesity. JAMA 308 (2012), 1070–1071.
116. Hernandez-Aguilera, A., Rull, A., Rodriguez-Gallego, E., Riera-Borrull, M., Luciano-Mateo, F., Camps, J., et al. Mitochondrial dysfunction: A basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediators Inflamm, 2013, 2013, 135698.
117. Koves, T.R., Ussher, J.R., Noland, R.C., Slentz, D., Mosedale, M., Ilkayeva, O., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7 (2008), 45–56.
118. Kusminski, C.M., Scherer, P.E., Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab 23 (2012), 435–443.
119. Montgomery, M.K., Turner, N., Mitochondrial dysfunction and insulin resistance: An update. Endocr Connect 4 (2015), R1–R15.
120. Muoio, D.M., Newgard, C.B., Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9 (2008), 193–205.
121. Green, D.R., Galluzzi, L., Kroemer, G., Cell biology. Metabolic control of cell death. Science, 345, 2014, 1250256.
122. Thakur, G.S., Daigle, B.J. Jr., Dean, K.R., Zhang, Y., Rodriguez-Fernandez, M., Hammamieh, R., et al. Systems biology approach to understanding post-traumatic stress disorder. Mol Biosyst 11 (2015), 980–993.
123. Friedrich, N., Metabolomics in diabetes research. J Endocrinol 215 (2012), 29–42.
124. Swarbrick, M.M., Havel, P.J., Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6 (2008), 87–102.
125. Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
126. Frey, W.H. 2nd, Intranasal insulin to treat and protect against posttraumatic stress disorder. J Nerv Ment Dis 201 (2013), 638–639.
127. Valero, T., Mitochondrial biogenesis: Pharmacological approaches. Curr Pharm Des 20 (2014), 5507–5509.
128. Rolland, B., Deguil, J., Jardri, R., Cottencin, O., Thomas, P., Bordet, R., Therapeutic prospects of PPARs in psychiatric disorders: A comprehensive review. Curr Drug Targets 14 (2013), 724–732.
129. Fisman, E.Z., Tenenbaum, A., Adiponectin: A manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?. Cardiovasc Diabetol, 13, 2014, 103.
130. Miller, A.H., Haroon, E., Felger, J.C., Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation. Neuropsychopharmacology 42 (2017), 334–359.
131. Yehuda, R., Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci 1179 (2009), 56–69.
132. Parikh, S., Saneto, R., Falk, M.J., Anselm, I., Cohen, B.H., Haas, R., et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 11 (2009), 414–430.
133. Kanabus, M., Heales, S.J., Rahman, S., Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol 171 (2014), 1798–1817.
134. Friedrich, M.J., Studies probe mechanisms that have a role in obesity-associated morbidities. JAMA 308 (2012), 1077–1079.